“CHIP”s are bad for patients with solid tumors

    loading  Checking for direct PDF access through Ovid

Abstract

In patients with non-hematologic cancers, clonal hematopoiesis is prevalent, increases risk of developing a hematologic malignancy, and decreases overall survival.

Related Topics

    loading  Loading Related Articles